Lazard Healthcare Acquisition Corp. I (LHCA) RWRegistration withdrawal request

Lazard Healthcare Acquisition Corp. I

30 Rockefeller Plaza

New York, NY 10112

VIA EDGAR

Re: Lazard Healthcare Acquisition Corp. I

Application for Withdrawal of Registration Statement on Form S-1

(File No. 333-254545)

On March 19, 2021, Lazard Healthcare Acquisition Corp. I, a Cayman Islands exempted company (the “Company”), initially filed Registration Statement No. 333-254545 on Form S-1 (together with all exhibits and amendments thereto, the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”).

In accordance with Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby respectfully makes this application to withdraw the Registration Statement, together with all exhibits thereto.

No securities have been issued or sold under the Registration Statement. The Registration Statement has not been declared effective by the Commission. The Company is seeking withdrawal of the Registration Statement because it is not currently pursuing a public offering of securities.  Based on the foregoing, the Company submits that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by Rule 477(a) under the Securities Act.

The Company respectfully requests that the Commission issue an order granting withdrawal of the Registration Statement. Please provide a copy of the order granting withdrawal of the Registration Statement to Mary Ann Deignan, Chief Financial Officer, Lazard Healthcare Acquisition Corp. I, at the address first mentioned above, with a copy to Company’s counsel,  Cravath, Swaine & Moore LLP, 825 Eighth Avenue, New York, NY 10019, attention: Nicholas A. Dorsey, email: NDorsey@cravath.com.

The Company acknowledges that no refund will be made for fees paid to the Commission in connection with the filing of the Registration Statement.  However, in accordance with Rule 457(p) under the Securities Act, the Company requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.

If you have any questions or comments or require further information regarding this application of withdrawal of the Registration Statement, please contact Nicholas A. Dorsey at (212) 474-1764.